Given the weakness seen on Monday, should you be worried regarding stocks from this sector? Here is how they look on the charts
Dr Lal PathLabs' stock seems to have lost its sheen now as we are seeing consistent corrective moves over the past few weeks
HEG stock after trading with a strong uptrend recently underwent some consolidation
Some brokerages prefer Metropolis given higher realisation, revenue growth trajectory
According to the Union Health Ministry data, India recorded 1,03,558 coronavirus infections on Sunday, pushing the nationwide Covid tally to 1.25 crore
The company would continue to reap benefits from increased Covid-related and allied testing in its widespread network of diagnostic centers and labs, analysts believe
Higher competition, expansion may be a challenge for margin
Better-than-expected Q2 GDP data numbers might help index to move in the positive territory
From March lows, the stock price of Thyrocare Technologies has been more-than-tripled and of Dr Lal PathLabs more-than-doubled on the BSE
A new all time high shows bullish sentiment is here to stay in these stocks.
Thyrocare Technologies, Metropolis Healthcare and Dr. Lal PathLabs, hitting their respective record highs, were up 9 per cent to 17 per cent on the BSE in intra-day trade.
All indicators point to a gradual rise in Aurobindo Pharma's stock from the 100 EMA support
The 29 per cent fall in volumes in the quarter was responsible for revenues declining 21 per cent year-on-year
Valuations too do not leave much scope for gains
Diagnostic services provider Dr Lal PathLabs on Friday reported a 51.94 per cent decline in its consolidated net profit at Rs 28.4 crore for the quarter ended June 30, 2020.
Metropolis Healthcare, meanwhile, rallied 7% to Rs 1,579 today, and were trading higher for the eighth straight day
Firm will be scaling up its capacity up to 2,000-2,500 tests a day as per ICMR norms by next week
That apart, national laboratories have also been allowed to carry out clinical testing of Covid-19, as the number of cases went past 400 in India.
Awards announced for nine other categories; Adi Godrej gets Lifetime achievement award
Expansion, raising share of B2C network to help improve margins